Old Web
English
Sign In
Acemap
>
authorDetail
>
L.A. Cancel-Treviño
L.A. Cancel-Treviño
Nivolumab
Antibody
Ipilimumab
Antigen
Immunotherapy
1
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Nivolumab and ipilimumab in the treatment of metastatic renal cell carcinoma. Report of two patients
2017
Medicina Universitaria
L.A. Cancel-Treviño
Y. López-Chuken
D. Hernandez Barajas
A. Velazquez-Pacheco
Show All
Source
Cite
Save
Citations (1)
1